potassium chloride extended-release (70010-135)

Drug Facts

Product Profile

Brand Name potassium chloride extended-release

Generic Name potassium chloride extended-release

Labeler granules pharmaceuticals inc.

Dosage Form TABLET, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

potassium chloride 1500 mg/1

Manufacturer

Granules Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 70010-135

Product ID 70010-135_495d2e0b-e6b6-958e-e063-6394a90ac328

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA214452

Listing Expiration 2027-12-31

Marketing Start 2021-01-30

Pharmacologic Class

Classes

increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70010135

Hyphenated Format 70010-135

Supplemental Identifiers

RxCUI

1801294 1801298

UPC

0370010135017

UNII

660YQ98I10

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name potassium chloride extended-release (source: ndc)

Generic Name potassium chloride extended-release (source: ndc)

Application Number ANDA214452 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

1500 mg/1

source: ndc

Packaging

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-01)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-05)
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-10)

source: ndc

Packages (3)

70010-135-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-01) 70010-135-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-05) 70010-135-10 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-10)

Ingredients (1)

potassium chloride (1500 mg/1)

Linked Drug Pages (1)

Potassium Chloride Extended-release ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "495d2e0b-e6b6-958e-e063-6394a90ac328", "openfda": {"upc": ["0370010135017"], "unii": ["660YQ98I10"], "rxcui": ["1801294", "1801298"], "spl_set_id": ["b3d4d5b5-2898-ae3d-e053-2a95a90a6d04"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-01)", "package_ndc": "70010-135-01", "marketing_start_date": "20210130"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-05)", "package_ndc": "70010-135-05", "marketing_start_date": "20210130"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-135-10)", "package_ndc": "70010-135-10", "marketing_start_date": "20210130"}], "brand_name": "Potassium Chloride Extended-release", "product_id": "70010-135_495d2e0b-e6b6-958e-e063-6394a90ac328", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]"], "product_ndc": "70010-135", "generic_name": "Potassium Chloride Extended-release", "labeler_name": "Granules Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Chloride Extended-release", "active_ingredients": [{"name": "POTASSIUM CHLORIDE", "strength": "1500 mg/1"}], "application_number": "ANDA214452", "marketing_category": "ANDA", "marketing_start_date": "20210130", "listing_expiration_date": "20271231"}